Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Maruzzo

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Anticancer Research|July 2, 2014
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experienceCharlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, et al.
Clinical Genitourinary Cancer|May 10, 2023
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial CarcinomaFrancesco Pierantoni, Michele Dionese, Umberto Basso, et al.
Journal of Geriatric Oncology|January 29, 2019
Prevalence of pain in patients with cancer aged 70 years or older: A prospective observational studyAntonella Brunello, Selma Ahcene-Djaballah, Annunziata Lettiero, et al.
Cell Reports|May 18, 2016
Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell CarcinomaFrancesco Gatto, Nicola Volpi, Helén Nilsson, et al.
Cancer Medicine|February 24, 2024
What do cancer patients experience of the simultaneous care clinic? Results of a cross-sectional study on patient care satisfactionAntonella Galiano, Alessandra Feltrin, Ardi Pambuku, et al.
Current Oncology Reports|November 8, 2021
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, et al.
Anticancer Research|December 31, 2021
The Role of Fast and Deep PSA Response in Castration-sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Orazio Caffo, et al.
Tumori|June 30, 2026
End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, ItalyValter Giantin, Chiara Curreri, Caterina Ugolini, et al.
Journal of Translational Medicine|August 4, 2021
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigatorsMarco Stellato, Giuseppe Procopio, Ugo De Giorgi, et al.
Journal of Cancer Research and Clinical Oncology|November 9, 2015
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experienceAntonella Brunello, Mario Domenico Rizzato, Marco Rastrelli, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Anticancer Research|July 2, 2014
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experienceCharlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, et al.
Clinical Genitourinary Cancer|May 10, 2023
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial CarcinomaFrancesco Pierantoni, Michele Dionese, Umberto Basso, et al.
Journal of Geriatric Oncology|January 29, 2019
Prevalence of pain in patients with cancer aged 70 years or older: A prospective observational studyAntonella Brunello, Selma Ahcene-Djaballah, Annunziata Lettiero, et al.
Cell Reports|May 18, 2016
Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell CarcinomaFrancesco Gatto, Nicola Volpi, Helén Nilsson, et al.
Cancer Medicine|February 24, 2024
What do cancer patients experience of the simultaneous care clinic? Results of a cross-sectional study on patient care satisfactionAntonella Galiano, Alessandra Feltrin, Ardi Pambuku, et al.
Current Oncology Reports|November 8, 2021
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, et al.
Anticancer Research|December 31, 2021
The Role of Fast and Deep PSA Response in Castration-sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Orazio Caffo, et al.
Tumori|June 30, 2026
End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, ItalyValter Giantin, Chiara Curreri, Caterina Ugolini, et al.
Journal of Translational Medicine|August 4, 2021
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigatorsMarco Stellato, Giuseppe Procopio, Ugo De Giorgi, et al.
Journal of Cancer Research and Clinical Oncology|November 9, 2015
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experienceAntonella Brunello, Mario Domenico Rizzato, Marco Rastrelli, et al.
Pageof 15